Loading clinical trials...
Loading clinical trials...
A Cross-Sectional Patient-Reported Study To Assess The Patient Preference Of Treatment Administration Setting, Impact On Health-Related Quality Of Life, Work Productivity, Wider Societal Costs And Healthcare Utilisation For Patients With Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Prescribed Somatuline® Autogel® In A Homecare Setting and Hospital Setting.
Conditions
Locations
5
United Kingdom
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Cardiff and Vale University LHB
Cardiff, United Kingdom
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, United Kingdom
Liverpool University Hospitals NHS Foundation Trust
Liverpool, United Kingdom
Royal Free London NHS Foundation Trust
London, United Kingdom
Start Date
April 27, 2021
Primary Completion Date
June 5, 2022
Completion Date
June 5, 2022
Last Updated
December 17, 2024
Lead Sponsor
Ipsen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions